← All trials
NCT06731764
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 10, 2024
- Primary completion
- Jan 1, 2027
- Completion date
- Jun 30, 2027
- First posted
- Dec 12, 2024
- Last posted
- Dec 12, 2024
- Enrollment
- 90
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of ConnecticutLead sponsor
- University of ConnecticutSponsor investigator
- University of ConnecticutOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.